BRMS1 anticorps (AA 151-246) (Biotin)

N° du produit ABIN1400173

Détail du produit anti-BRMS1 anticorps (Biotin)

Antigène: BRMS1 (Breast Cancer Metastasis Suppressor 1 (BRMS1))

Épitope: AA 151-246

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BRMS1 est conjugé à/à la Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Réactivité croisée: Humain, Souris, Rat

Homologie: Dog,Pig,Horse

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human BRMS1

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur BRMS1

Antigène: BRMS1 (Breast Cancer Metastasis Suppressor 1 (BRMS1))

Autre désignation: BRMS1 (BRMS1 Produits)

Synonymes: anticorps MGC98869, anticorps BRMS1, anticorps BRMS1L, anticorps AV003220, anticorps AW554636, anticorps si:zc188c22.3, anticorps si:zc194c5.2, anticorps wu:fb57b08, anticorps zgc:56414, anticorps breast cancer metastasis suppressor 1, anticorps breast cancer metastasis-suppressor 1, anticorps breast cancer metastasis suppressor 1 L homeolog, anticorps BRMS1, anticorps Brms1, anticorps brms1.L, anticorps brms1

Sujet:

Synonyms: Breast cancer metastasis suppressor 1, Breast cancer metastasis-suppressor 1, BRMS-1, BRMS1_HUMAN, DKFZp564A063, MGC95128, AV003220, AW554636.

Background: Breast cancer metastasis-suppressor 1 (BRMS1) is 246 amino acid protein that acts as a mediator of metastasis suppression in several types of cancer including ovarian, lung, bladder, and murine mammary. BRMS1 mRNA is expressed in various tissues, including ovary, prostate, testis, and colon, but the protein is primarily detected in term placenta. BRMS1 suppresses metastasis without inhibiting tumorigenicity by modifying several metastasis-associated phenotypes. BRMS1 may participate in transcriptional regulation by binding to the mSin3/histone deacetylase complex. The expression of BRMS1 in certain cells increases connexin Cx43 expression and reduces connexin Cx32 expression. This produces a gap junction that increases intercellular communication, similar to those found in normal breast tissue. BRMS1 is stabilized by Hsp90 and may inhibit NF-_B activity.